Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iD Innovation is a French medical technology company specializing in the development of innovative drug delivery systems, particularly for intradermal and subcutaneous administration. The company's flagship technology, the iD-System, is designed to provide precise, easy-to-use, and less painful injection solutions for vaccines, biologics, and aesthetic treatments. By targeting the dermis, their technology aims to enhance the immune response and improve patient compliance. iD Innovation collaborates with pharmaceutical and biotech partners to integrate its delivery platforms with various therapeutic agents. The company focuses on addressing the technical challenges of intradermal injection to enable wider adoption of dose-sparing vaccination strategies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iD Innovation.